Abstract:BackgroundIn the United States, about 3 million people have autism spectrum disorder (ASD), and around 1 out of 59 children are diagnosed with ASD. People with ASD have characteristic social communication deficits and repetitive behaviors. The causes of this disorder remain unknown; however, in up to 25% of cases, a genetic cause can be identified. Detecting ASD as early as possible is desirable because early detection of ASD enables timely interventions in children with ASD. Identification of ASD based on objective pathogenic mutation screening is the major first step toward early intervention and effective treatment of affected children. ObjectiveRecent investigation interrogated genomics data for detecting and treating autism disorders, in addition to the conventional clinical interview as a diagnostic test. Since deep neural networks perform better than shallow machine learning models on complex and high-dimensional data, in this study, we sought to apply deep learning to genetic data obtained across thousands of simplex families at risk for ASD to identify contributory mutations and to create an advanced diagnostic classifier for autism screening. MethodsAfter preprocessing the genomics data from the Simons Simplex Collection, we extracted top ranking common variants that may be protective or pathogenic for autism based on a chi-square test. A convolutional neural network–based diagnostic classifier was then designed using the identified significant common variants to predict autism. The performance was then compared with shallow machine learning–based classifiers and randomly selected common variants. ResultsThe selected contributory common variants were significantly enriched in chromosome X while chromosome Y was also discriminatory in determining the identification of autistic individuals from nonautistic individuals. The ARSD, MAGEB16, and MXRA5 genes had the largest effect in the contributory variants. Thus, screening algorithms were adapted to include these common variants. The deep learning model yielded an area under the receiver operating characteristic curve of 0.955 and an accuracy of 88% for identifying autistic individuals from nonautistic individuals. Our classifier demonstrated a considerable improvement of ~13% in terms of classification accuracy compared to standard autism screening tools. ConclusionsCommon variants are informative for autism identification. Our findings also suggest that the deep learning process is a reliable method for distinguishing the diseased group from the control group based on the common variants of autism.

Discovery and validation of novel genes in a large Chinese ASD cohort

Autism Spectrum Disorder Early in Development Associated with CHD8 Mutations among Two Chinese Children

Whole-genome sequencing identifies novel genes for autism in Chinese trios

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

Identification of De Novo Mutations in the Chinese ASD Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Targeted Resequencing of 358 Candidate Genes for Autism Spectrum Disorder in a Chinese Cohort Reveals Diagnostic Potential and Genotype-Phenotype Correlations

Genomic Landscapes of Chinese Sporadic Autism Spectrum Disorders Revealed by Whole-Genome Sequencing.

Targeted sequencing and integrative analysis of 3,195 Chinese patients with neurodevelopmental disorders prioritized 26 novel candidate genes

De novo genic mutations among a Chinese autism spectrum disorder cohort

Targeted Sequencing and Clinical Strategies in Children with Autism Spectrum Disorder: A Cohort Study

Unraveling the immunogenetic landscape of autism spectrum disorder: a comprehensive bioinformatics approach

Clinical Targeted Panel Sequencing Analysis in Clinical Evaluation of Children with Autism Spectrum Disorder in China

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder

A Sex-Specific Association of Common Variants of Neuroligin Genes (NLGN3 and NLGN4X) with Autism Spectrum Disorders in a Chinese Han Cohort

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

The genetic landscape of autism spectrum disorder in an ancestrally diverse cohort

Autism spectrum disorder and comorbid neurodevelopmental disorders (ASD-NDDs): Clinical and genetic profile of a pediatric cohort

Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidates

Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks

Convergent Coexpression of Autism-Associated Genes Suggests Some Novel Risk Genes May Not Be Detectable in Large-Scale Genetic Studies.